Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Alto Neuroscience, Inc. (ANRO) had Debt to Capital Ratio of 0.06 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-26.24M |
|
-- |
|
-- |
|
$27.14M |
|
$-27.14M |
|
$0.90M |
|
$-26.24M |
|
$-26.24M |
|
$-26.24M |
|
$-26.24M |
|
$-26.24M |
|
$-26.24M |
|
$-27.14M |
|
$-26.95M |
|
32.89M |
|
32.89M |
|
$-0.80 |
|
$-0.80 |
|
| Balance Sheet Financials | |
$269.13M |
|
$2.23M |
|
$7.13M |
|
$276.26M |
|
$13.12M |
|
$16.22M |
|
$19.77M |
|
$32.89M |
|
$243.37M |
|
$243.37M |
|
$243.37M |
|
35.05M |
|
| Cash Flow Statement Financials | |
$-27.09M |
|
$-0.56M |
|
$114.94M |
|
$176.98M |
|
$264.26M |
|
$87.28M |
|
$2.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.52 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.06 |
0.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-27.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.78% |
|
-10.78% |
|
-9.50% |
|
-10.11% |
|
$6.94 |
|
$-0.84 |
|
$-0.82 |
|